LONG-TERM treatment with inhaled corticosteroids has been shown to result in improvement of symptoms and lung function in subjects with asthma. Arachidonic acid (AA) metabolites are thought to play a role in the pathophysiology of asthma. It was assessed whether differences could be found in bronchoalveolar lavage (BAL) AA metabolite levels between subjects with asthma who were treated for 2.5 years with inhaled bronchodilators alone or in combination with inhaled corticosteroids. Prostaglandin (PG)D2, PGF2, 6-keto-PGFa, thromboxane B2, leukotriene (LT)C and LTB levels and cell numbers were assessed in BAL fluid from 22 non-smoking asthmatic subjects. They were participating in a randomized, double-blind multicentre drug trial over a period of 2.5 years. Results of the group treated with inhaled corticosteroids (CS+: beclomethasone 200g four times daily) were compared with the other group (CS-) which was treated with either ipratropium bromide (40g four times daily) or placebo. BAL LTC levels of asthmatic subjects were significantly lower after 2.5 years inhaled corticosteroid therapy (CS+, 9(1-17) pg/ml vs. CS-, 16(6-53) pg/ml; p 0.01). The same trend was observed for the PGD2 levels.
Introduction
Recent long-term studies on the prognosis and morbidity of obstructive airways disease have shown that addition of inhaled corticosteroids to maintenance treatment with a 2-agonist in hyper-responsive patients with obstructive airways disease leads to a significant reduction of respiratory symptoms, exacerbation rates, airway 12 obstruction and airway hyper-responsiveness. These findings are thought to be a consequence of We did not find a difference in total or differential cell numbers between the groups. Previous findings in studies on the effect of short-term corticosteroid treatment (6 weeks to 4 months) on BAL cell numbers are not consistent, although in the majority a reduction of BAL eosinophil numbers was found. 15'16'22'23 It cannot be excluded that we did not find differences as a consequence of group sizes that were too small. Inflammatory processes in the airways are, however, probably better reflected by cell activation than increased cell numbers in the BAL fluid, as has been found in this study.
In conclusion, this study shows that BAL LTC4 levels of asthmatic subjects were significantly lower after 2.5 years inhaled corticosteroid therapy. The results suggest that corticosteroids may exert their beneficial effect on lung function via a mechanism in which inhibition of LTC4 synthesis in the airways is involved.
